INVERNIZZI PIETRO

Ciardullo, S., Carbone, M., Invernizzi, P., Perseghin, G. (2023). Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States. DIABETES RESEARCH AND CLINICAL PRACTICE [10.1016/j.diabres.2023.110679]. Detail

Cordell, H., Fryett, J., Ueno, K., Darlay, R., Aiba, Y., Hitomi, Y., et al. (2023). Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] [Altro] [10.1016/j.jhep.2022.12.001]. Detail

Murillo Perez, C., Gerussi, A., Trivedi, P., Corpechot, C., Van Der Meer, A., Maria Battezzati, P., et al. (2023). Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 35(1), 112-119 [10.1097/MEG.0000000000002464]. Detail

Cristoferi, L., Porta, M., Bernasconi, D., Leonardi, F., Gerussi, A., Mulinacci, G., et al. (2023). A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. DIGESTIVE AND LIVER DISEASE, 55(3 (March 2023)), 373-380 [10.1016/j.dld.2022.10.015]. Detail

Cristoferi, L., Ciardullo, S., Invernizzi, P., Perseghin, G., Carbone, M. (2023). Endocrinology and Metabolic Diseases (Including Diabetes). In G.M. Hirschfield, P. Gill, J. Neuberger (a cura di), The Liver in Systemic Disease: A Clinician's Guide to Abnormal Liver Tests (pp. 99-109). Gideon M. Hirschfield, Paramjit Gill, James Neuberger [10.1002/9781119802181.ch8]. Detail